A highly active anticomplement factor from the venom of Naja kaouthia

Acta Biochimica et Biophysica Sinica

Volumn 33, Issue 5, 2001, Pages 483-488

  Sun, Qian Yun ^a   Lu, Qiu Min ^a   Wang, Wan Yu ^a   Xiong, Yu Liang ^a  

^a KUNMING INSTITUTE OF ZOOLOGY   (China)

Author keywords

Anticomplement factor; Complement; Venom

Indexed keywords

EID: 0035602272     PISSN: 05829879     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Ballow M, Cochrane C G. Two anticomplementary factors in cobra venom: Hemolysis of guinea pig erythrocytes by one of them. J Immunol, 1969, 103(5): 944-952
2. Eggertsen G, Lind P, Sjöquist J. Molecular characterization of the complement activating protein in the venom of the Indian cobra (Naja N. Siamensis). Mol Immunol, 1981, 18: 125-133
3. Takahashi H, Hayashi K. Purification and characterization of anticomplement factor (cobra venom factor) from the Naja naja atra venom. Biochim Biophys Acta, 1982, 701: 102-110
4. Vogel C W, Müller-Eberhard H J. Cobra venom factor: Improved method for purification and biochemical characterization. J Immunol Med, 1984, 73: 203-220
5. Shu Y Y, Cheng C, Zhuang M X, Tang S X. Purification and characterization of cobra venom factor from Chinese cobra (Naja naja atra). Acta Biochimica et Biophysica Sinica, 1991, 23 (1): 32-39
6. Götze O, Müller-eberhard H J. The C3 activator system: An alternate pathway of complement activation. J Exp Med, 1971, 134(3): 90s-108s
7. Hunsicker L G, Ruddy S, Austen K F. Alternate complement pathway: Factors involved in cobra venom factor (CoVF) activation of the third component of complement (C3). J Immunol, 1973, 110(1): 128-138
8. Miyama A, Kato T, Minodal, Ucda T, Kashiba S. Activation of terminal components of human complement by a trypsin-activated complex of human factor B and cobra venom factor. Japan J Microbiol, 1976, 20(6): 507-516
9. Vogel C W, Müller-Eberhard H J. The cobra venom factor-dependent C3 convertase of human complement. J Biol Chem, 1982, 257: 8292-8299
10. Cochrane C G, Müller-Eberhard H J, Aikin B S. Depletion of plasma complement in vivo by a protein of cobra venom: Its effect on various immunologic reactions. J Immunol, 1970, 105(1): 55-69
11. Vogel C W, Welt S, Carswell E A, Old L J, Müller-Eberhard H J. A murine IgG3 monoclonal antibody to a melanoma antigen that activates complement in vitro and in vivo. 10th International Complement Workshop, Mainz. Immunobiology, 1983, 164: 309
12. Hill J H, Ward P A. The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats. J Exp Med, 1971, 133 (4): 885-900
13. Fong J S C, Good R A. Prevention of the localized and generalized Shwartzman reactions by an anticomplementary agent, cobra venom factor. J Exp Med, 1971, 134(3): 642-655
14. Leventhal J R, Dalmasso A P, Cromwell J W, Platt J L, Manivel C J, Bolman III R M, Matas A J. Prolongation of cardiac xenograft survival by depletion of complement. Transplantation, 1993, 55(4): 857-866
15. Kobayashi T, Taniguchi S, Neethling F A, Rose A G, Hancock W W, Ye Y, Niekrasz M et al. Delayed xenograft rejection of pig-to-baboon cardiac transplants after cobra venom factor therapy. Transplantation, 1997, 64(9): 1255-1261
16. Laemmli U K. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature, 1970, 227: 680-685
17. Hames B D, Richwood D eds. Gel Electrophoresis of Proteins. Beijing: Science Press, 1986, 13-14
18. Guan L F, Qi Z W. Study on thrombin-like enzyme from the venom of Agkistrodon halys Pallas I. Acta Biochimica et Biophysica Sinica, 1982, 14(4): 303-313
19. Zhang Y S. Phenol-sulfuric acid method. In: Zhang W J ed. Biochemical Techniques in Complex Potysaccharide Research, Shanghai: Shanghai Scientific and Technical Publisher, 1987, 6-7
20. Spackman D H, Stein W H, Moore S. Automatic recording apparatus for use in the chromatography of amino acids. Anal Chem, 1958, 30: 1190-1206
21. Kabat E A, Mayer M M eds. Experimental Immunochemistry, 2nd, Springfield, IL: Charles C Thomas, 1961, 149-153
22. Pepys M B, Tompkins C, Smith A D. An improved method for the isolation from Naja naja venom of cobra factor (CoF) free of phospholipase A. J Immunol Med, 1979, 30: 105-117
23. Candinas D, Lesnikoski B A, Robson S C, Miyatake T, Scesney S M, Marsh H C Jr, Ryan U S et al. Effect of repetitive high-dose treatment with soluble complement receptor type 1 and cobra venom factor on discordant xenograft survival. Transplantation, 1996, 62(3): 336-342
24. Hayashi S, Ito M, Yokoyama I, Takagi H. Evidence that combination therapy using cobra venom factor, splenectomy, and deoxyspergualin is effective in guinea pig to rat cardiac xenotransplantation. Transplantation, 1994, 57(5): 777-779